SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-011424
Filing Date
2017-02-16
Accepted
2017-02-16 16:03:20
Documents
1
Period of Report
2017-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 27375
  Complete submission text file 0001209191-17-011424.txt   28796
Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
DUYK GEOFFREY M (Reporting) CIK: 0001202090 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36152 | Film No.: 17617890

Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Issuer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)